RSS   Newsletter   Contact   Advertise with us
Post Online Media

Eleven Biotherapeutics appoints Richard F. Fitzgerald as interim CFO

Eleven BiotherapeuticsEleven Biotherapeutics, a late-stage clinical oncology company, announced the appointment of Richard F. Fitzgerald as interim chief financial officer.
Article continues below

READ MORE Gregory D. Perry new CFO of Aegerion Pharmaceuticals

Mr. Fitzgerald brings over two decades of financial and strategic leadership to Eleven Biotherapeutics.

Most recently, he served as a consultant to private life science based companies from July 2017 through October 2017.

Before that, Mr. Fitzgerald served as Chief Financial officer of Pavmed Inc., where he completed its IPO in April 2016.

He previously served as Chief Financial Officer at Techprecision Corporation and Nucleonics Inc., and in several financial and business development positions of increasing responsibility at Exelon Corporation.

Mr. Fitzgerald holds his B.S. in Business Administration from Bucknell University.

 LATEST MOVES FROM Massachusetts 


We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy